Src
Src(Src激酶)
Src (proto-oncogene tyrosine-protein kinase) is a non-receptor protein tyrosine kinase family including 9 members and promotes survival, angiogenesis, proliferation and invasion pathways.
Src 相关产品(101)
- GC14007DCC-2036 (Rebastinib)CAS: 1020172-07-9纯度: >99.50%
An orally bioavailable tyrosine kinase inhibitor
- GC14396Ponatinib (AP24534)CAS: 943319-70-8纯度: >99.00%
Ponatinib (AP24534)是一种多靶点酪氨酸激酶抑制剂,可抑制Abl(IC 50 =0.37nM),PDGFRα(IC 50 =1.1nM),VEGFR2(IC 50 =1.5nM),FGFR1(IC 50 =2.2nM)和Src(IC 50 =5.4nM)的活性。
- GC15568Dasatinib (BMS-354825)CAS: 302962-49-8纯度: >99.50% / >98.00%
Dasatinib (BMS-354825)是一种高效、口服生物利用度高的多靶点酪氨酸激酶抑制剂,对BCR-ABL、SRC家族激酶、c-KIT和PDGFR-β的IC₅₀分别为0.4nM、0.5nM、100nM和180nM。
- GC17137pp60 c-src (521-533) (phosphorylated)CAS: 149299-77-4
Peptide corresponding to the pp60c-src carboxy terminal regulatory domain
- GC31701RK-24466 (KIN 001-51)CAS: 213743-31-8纯度: >98.50%
A selective inhibitor of lymphocyte- specific protein tyrosine kinase
- GC329927-Hydroxy-4-chromone (7-Hydroxychromone)CAS: 59887-89-7纯度: >98.00%
7-Hydroxychromone is an inhibitor of Src kinase with IC50 of <300 μM.
- GC33181T338C Src-IN-2CAS: 1351927-00-8
T338CSrc-IN-2是突变型c-Src激酶抑制剂,IC50值317nM,还能抑制T338C/V323A和T338C/V323S双突变Src活性,IC50值57和19nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14007 | DCC-2036 (Rebastinib) | 1020172-07-9 | >99.50% | |
An orally bioavailable tyrosine kinase inhibitor | ||||
| GC14292 | Apatinib Mesylate | 811803-05-1 | >98.00% | |
A selective VEGFR2 inhibitor | ||||
| GC14396 | Ponatinib (AP24534) | 943319-70-8 | >99.00% | |
Ponatinib (AP24534)是一种多靶点酪氨酸激酶抑制剂,可抑制Abl(IC 50 =0.37nM),PDGFRα(IC 50 =1.1nM),VEGFR2(IC 50 =1.5nM),FGFR1(IC 50 =2.2nM)和Src(IC 50 =5.4nM)的活性。 | ||||
| GC15000 | Herbimycin A | 70563-58-5 | - | |
An inhibitor of tyrosine kinases and Hsp90 | ||||
| GC15211 | Damnacanthal | 477-84-9 | - | |
Damnacanthal 是一种从海巴戟根中分离出来的蒽醌。 | ||||
| GC15568 | Dasatinib (BMS-354825) | 302962-49-8 | >99.50% / >98.00% | |
Dasatinib (BMS-354825)是一种高效、口服生物利用度高的多靶点酪氨酸激酶抑制剂,对BCR-ABL、SRC家族激酶、c-KIT和PDGFR-β的IC₅₀分别为0.4nM、0.5nM、100nM和180nM。 | ||||
| GC16519 | ENMD-2076 | 934353-76-1 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC16957 | Src I1 | 179248-59-0 | >99.50% | |
A potent inhibitor of Src kinases | ||||
| GC17137 | pp60 c-src (521-533) (phosphorylated) | 149299-77-4 | - | |
Peptide corresponding to the pp60c-src carboxy terminal regulatory domain | ||||
| GC17473 | Pelitinib (EKB-569) | 257933-82-7 | >98.00% | |
An EGFR receptor tyrosine kinase inhibitor | ||||
| GC17500 | SU6656 | 330161-87-0 | - | |
SU6656是一种小分子吲哚酮类化合物,可选择性抑制Src、Yes和Fyn激酶活性,IC 50 值分别为0.28μM、0.02μM和0.17μM。 | ||||
| GC17638 | KB SRC 4 | 1380088-03-8 | >99.50% | |
KB SRC 4 是一种有效的、高选择性的 c-Src 抑制剂,Ki 为 44 nM,Kd 为 86 nM,对 c-Abl 没有抑制作用,最高可达 125 μM; KB SRC 4 具有抗肿瘤活性。 | ||||
| GC17669 | AMG-47A | 882663-88-9 | >98.50% | |
A multi-kinase inhibitor | ||||
| GC18438 | CGP 77675 | 234772-64-6 | >98.00% | |
CGP 77675是一种高效的酪氨酸激酶Src抑制剂,其抑制纯化Src的自磷酸化反应的IC 50 为40nM。 | ||||
| GC19366 | UM-164 | 903564-48-7 | >98.50% | |
An inhibitor of Src and p38 MAPK kinases | ||||
| GC26001 | TPX-0046 | 2359650-19-2 | - | |
TPX-0046 is a novel RET/SRC inhibitor with a mean IC50 of 17 nM for RETG810R in Ba/F3 cell proliferation assay | ||||
| GC31701 | RK-24466 (KIN 001-51) | 213743-31-8 | >98.50% | |
A selective inhibitor of lymphocyte- specific protein tyrosine kinase | ||||
| GC32797 | AD80 | 1384071-99-1 | >99.50% | |
AD80, a multikinase inhibitor, shows strong activity against human RET (c-RET), BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM. | ||||
| GC32825 | eCF506 | 1914078-41-3 | >99.00% | |
An inhibitor of Src kinases | ||||
| GC32835 | PP58 | 212391-58-7 | >99.00% | |
PP58是吡啶[2,3-d]嘧啶化合物,抑制PDGFR,FGFR和Src家族活性的IC50值在纳摩尔级。 | ||||
| GC32875 | AZM475271 (M475271) | 476159-98-5 | >99.50% | |
An inhibitor of c-Src kinase | ||||
| GC32992 | 7-Hydroxy-4-chromone (7-Hydroxychromone) | 59887-89-7 | >98.00% | |
7-Hydroxychromone is an inhibitor of Src kinase with IC50 of <300 μM. | ||||
| GC33168 | T338C Src-IN-1 | 1351926-90-3 | - | |
T338CSrc-IN-1是突变型c-SrcT338C高效抑制剂,IC50值111nM。对WTSrc活性弱10倍以上。 | ||||
| GC33181 | T338C Src-IN-2 | 1351927-00-8 | - | |
T338CSrc-IN-2是突变型c-Src激酶抑制剂,IC50值317nM,还能抑制T338C/V323A和T338C/V323S双突变Src活性,IC50值57和19nM。 | ||||
